| Drug Type Small molecule drug | 
| Synonyms Guaifenesin/Hydrocodone Tartrate/Pseudoephedrine Hydrochloride, Guaifenesin/hydrocodone/pseudoephedrine, Hycofenix | 
| Action agonists | 
| Mechanism Opioid receptors agonists(Opioid receptors agonists), α-adrenergic receptor agonists(Alpha adrenergic receptor agonists) | 
| Therapeutic Areas | 
| Active Indication- | 
| Inactive Indication | 
| Originator Organization | 
| Active Organization- | 
| License Organization- | 
| Drug Highest PhaseWithdrawn | 
| First Approval Date United States (14 May 2015),  | 
| Regulation- | 
| Molecular FormulaC22H29NO10 | 
| InChIKeyZICRJLQTAUVSDU-NSJZFRMTSA-N | 
| CAS Registry34195-34-1 | 
| Indication | Highest Phase | Country/Location | Organization | Date | 
|---|---|---|---|---|
| Bronchitis | Preclinical | China  | 22 Jun 2013 | |
| Bronchitis | Preclinical | China  | 22 Jun 2013 | |
| Common Cold | Preclinical | China  | 22 Jun 2013 | |
| Common Cold | Preclinical | China  | 22 Jun 2013 | |
| Influenza, Human | Preclinical | China  | 22 Jun 2013 | |
| Influenza, Human | Preclinical | China  | 22 Jun 2013 | |
| Sinusitis | Preclinical | China  | 22 Jun 2013 | |
| Sinusitis | Preclinical | China  | 22 Jun 2013 | 





